Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.63 |
| ▸ | POLB | P06746 | 3/20 | 0.63 |
| ▸ | BLM | P54132 | 3/20 | 0.63 |
| ▸ | NSD2 | O96028 | 2/20 | 0.63 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.63 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 2/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | MTOR | P42345 | 1/20 | 0.58 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.58 |
| ▸ | ECE1 | P42892 | 1/20 | 0.49 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.49 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | RECQL | P46063 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | EGFR | P00533 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29886736 | 1.00 | MEN1 (0.63) | MEN1KMT2APOLBBLMNSD2 | |
| SCHEMBL11485540 | 0.92 | MEN1 (0.55) | MEN1KMT2APOLBBLMNSD2 | |
| SCHEMBL20334208 | 0.91 | MEN1 (0.58) | MEN1KMT2APOLBBLMNSD2 | |
| SCHEMBL15271779 | 0.90 | TOP2B (0.72) | MEN1KMT2APOLBBLMNSD2 | |
| SCHEMBL8603851 | 0.89 | TOP2B (0.62) | MEN1KMT2APOLBBLMNSD2 | |
| SCHEMBL16343951 | 0.89 | TOP2B (0.61) | MEN1KMT2APOLBBLMNSD2 | |
| SCHEMBL126055 | 0.88 | MAPT (0.59) | MEN1KMT2APOLBBLMNSD2 | |
| SCHEMBL11883445 | 0.87 | MAOA (0.58) | MEN1KMT2APOLBBLMNSD2 | |
| SCHEMBL4202380 | 0.86 | CYP19A1 (0.50) | MEN1KMT2APOLBBLMNSD2 | |
| SCHEMBL8600843 | 0.85 | MEN1 (0.56) | MEN1KMT2APOLBBLMNSD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4062171-B1 | A NOVEL REAGENT, CATAL'S REAGENT, AND KIT FOR USING IRON SULPHATE DETERMINATION BY COLORIMETRIC METHOD | T C UESKUEDAR UENIVERSITESI (TR) | 2023-12-27 | — | — | EP | disclosed |
| US-8420861-B2 | Anti-tumor compounds derived from 1,4,5,8-tetrachloroanthraquinone | ISHMAEL D RICHARD (US) | 2013-04-16 | — | — | US | disclosed |
| US-20090156807-A1 | Anti-tumor Compounds Derived From 1,4,5,8-tetrachloroanthraquinone | ISHMAEL D RICHARD | 2009-06-18 | — | — | US | disclosed |
| US-20090036638-A1 | Contrast Dyes for Inkjet Lithographic Printing Plates | AGFA GRAPHICS NV (BE) | 2009-02-05 | — | — | US | disclosed |
| US-20090036638-A1 | Contrast Dyes for Inkjet Lithographic Printing Plates | AGFA GRAPHICS NV (BE) | 2009-02-05 | — | — | US | disclosed |
| US-20080280055-A1 | Inkjet Lithographic Printing Plates and Method for Their Preparation | AGFA GRAPHICS NV (BE) | 2008-11-13 | — | — | US | disclosed |
| US-20080280055-A1 | Inkjet Lithographic Printing Plates and Method for Their Preparation | AGFA GRAPHICS NV (BE) | 2008-11-13 | — | — | US | disclosed |
| EP-0721447-B1 | ANTHRACENE DERIVATIVES FOR USE AS ANTICANCER AGENT OR DYE | UNIV NAPIER (GB) | 1998-02-25 | — | — | EP | disclosed |
| EP-0721447-A1 | ANTHRACENE DERIVATIVES FOR USE AS ANTICANCER AGENT OR DYE | NAPIER UNIVERSITY VENTURES LIMITED (GB) | 1996-07-17 | — | — | EP | disclosed |
| WO-1995009149-A1 | ANTHRACENE DERIVATIVES FOR USE AS ANTICANCER AGENT OR DYE | NAPIER UNIVERSITY VENTURES LIMITED (GB) | 1995-04-06 | — | — | WO | disclosed |
| EP-0170290-B1 | AMINO-ANTHRACENEDIONES-PLATINUM COMPLEXES USEFUL AS ANTI-CANCER COMPOUNDS | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1990-06-13 | — | — | EP | disclosed |
| US-4732893-A | ANTITUMOR AGENTS | BOEHRINGER BIOCHEMIA ROBIN S.P.A. (IT) | 1988-03-22 | — | — | US | disclosed |
| EP-0170290-A2 | Amino-anthracenediones-platinum complexes useful as anti-cancer compounds | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1986-02-05 | — | — | EP | disclosed |
| EP-0154117-A1 | Use of 1,4 bis(substituted) anthrachinones for the manufacture of immunosuppresiva | AMERICAN CYANAMID COMPANY (US) | 1985-09-11 | — | — | EP | disclosed |
| US-4540583-A | 1,4-BIS/AMINOETHYL-ANTHRAQUINONES | AMERICAN CYANAMID COMPANY (US) | 1985-09-10 | — | — | US | disclosed |
| US-4540788-A | CHELATE COMPOUNDS, ANTITUMOR AGENTS | AMERICAN CYANAMID COMPANY (US) | 1985-09-10 | — | — | US | disclosed |
| EP-0131787-A2 | Novel Schiff bases of (aminoalkyl or substituted aminoalkyl)-amino-9,10-anthracenediones | AMERICAN CYANAMID COMPANY (US) | 1985-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156807-A1 | Anti-tumor Compounds Derived From 1,4,5,8-tetrachloroanthraquinone | CASP4, CASP8, CASP1 | MEN1 2002/4885KMT2A 2406/4885POLB 2943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.